DOI: 10.12890/2025_005229
Monoclonal gammopathy of undetermined significance with associated necrotizing myopathy: a case report and review of the literature
Authors
abode@salud.unm.edu
Keywords
Monoclonal gammopathy, myopathyAbstract
Background: Monoclonal gammopathies encompass many types of plasma cell proliferative disorders ranging from benign to malignant. Monoclonal gammopathies that meet diagnostic criteria for monoclonal gammopathies of undetermined significance (MGUS) but with clinical manifestations are now being referred to as monoclonal gammopathies of clinical significance (MGCS). MGUS associated myopathies are a rare form of MGCS.
Case description: We present a case of MGUS associated necrotizing myositis. The patient had been previously diagnosed with MGUS and myositis around the same time, but prior testing had not revealed the etiology of the myopathy. Repeat biopsy and work-up revealed a necrotizing myopathy.
Discussion: MGUS associated myopathies are rare, with the most common being sporadic late-onset nemaline myopathy (SLONM-MGUS) and amyloid light chain (AL) amyloidosis-associated myopathy. MGUS associated necrotizing myopathy is even rarer. Because this condition is so uncommon, there are no standardized guidelines on how to treat this condition. Some case reports or studies suggest treating the myositis with standard of care for the myositis type without considering the monoclonal gammopathy while other studies have suggested that treating the monoclonal gammopathy would be beneficial in treating the associated clinical syndrome.
Conclusion: Our case report of MGUS associated necrotizing myopathy encourages internists to broaden their differential diagnosis of myopathy, increasing awareness of a condition that is still not well understood.
References
- Fermand JP, Bridoux F, Dispenzieri A, Jaccard A, Kyle RA, Leung N, Merlini G. Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. Blood 2018;132:1478-1485.
- Oganesyan A, Gregory A, Malard F, Ghahramanyan N, Mohty M, et al. Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment. Front Immunol 2022;13:1045002.
- Yu H, He D, Zhang Q, Cao B, Liu W, Wu Y. Case Report: Monoclonal Gammopathies of Clinical Significance-Associated Myopathy: A Case-Based Review. Front Oncol 2022;12:914379.
- Wang M, Lei L, Chen H, Di L, Pang M, Lu Y, et al. Monoclonal gammopathy with both nemaline myopathy and amyloid myopathy. Neuromuscul Disord 2017;27:942-946.
- Kiprov DD, Miller RG. Polymyositis associated with monoclonal gammopathy. Lancet 1984;2:1183-1186.
- Gremain V, Litrowski N, Boulard C, Marguet F, Courville P, Zarnitsky C, et al. Necrotizing autoimmune myopathy associated with POEMS syndrome report. QJM 2018;111:49-50.
- Nakayama T, Horiuchi E, Watanabe T, Murayama S, Nakase H. A case of inclusion body myositis with benign monoclonal gammopathy successfully responding to repeated immunoabsorption. J Neurol Neurosurg Psychiatry 2000;68:230-233.
- Dalakas MC. Inflammatory muscle diseases. N Engl J Med 2015;372:1734-1747.
- Susman D, McLean J, Kotchetkov R. Sporadic late onset Nemaline Myopathy with a monoclonal gammopathy: Comparative effectiveness of immuno- and chemotherapy. Blood 2019;134:5820.
- Belhomme N, Maamar A, Le Gallou T, Minot-Myhié MC, Larralde A, Champtiaux N, et al. Rare myopathy associated to MGUS, causing heart failure and responding to chemotherapy. Ann Hematol 2017;96:695-696.
- Dispenzieri A. Monoclonal gammopathies of clinical significance. Hematology Am Soc Hematol Educ Program 2020;2020: 380–388.
- Schuster S, Rajkumar SV, Dispenzieri A, Morice W, Aspitia AM, Ansell S, et al. IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom’s macroglobulinemia. Am J Hematol 2010;85:853-855.
